Impact of allergic reactions and urticaria on mental health and quality of life
Main Article Content
Keywords
immediate-type hypersensitivity reactions, urticaria, mental health, quality of life, depression, allergies
Abstract
Background: Allergic diseases represent a major global health issue with more than one-third of the global population affected by at least one allergic condition. Allergic conditions can not only cause life-threatening anaphylactic reactions but also impact daily life with a significant influence on mental health and the quality of life (QoL).
Objectives: This study aims to evaluate the health-related QoL and depression severity among patients presenting in a tertiary care allergy center.
Methods: A cross-sectional study was conducted among 596 patients presenting with allergic symptoms or previously diagnosed allergies between October 2018 and April 2019.
Patients were screened for depression and the QoL impairment by using three validated scales: the Beck Depression Inventory (BDI), the Dermatologic Life Quality Index (DLQI), and the three-level version of the EuroQol 5-Dimensional (EQ-5D-3L) scale.
Results: One-third (34.8%) of the study population was male and two-thirds (65.2%) were female. About 73.7% (n = 427/579) of the patients suffered from at least one previously diagnosed allergic disease, most frequently to pollen (37.0%, n = 214/579) and food (27.3%, n = 158/579), and 20.0 % (n = 116/579) suffered from urticaria. About 19.3% of the total population suffered from depression. Urticaria, as well as insect venom, food/food additives, and drug allergies significantly affected the QoL and depression severity (p < 0.001), reflected by higher DLQI and BDI scores, and lower scores in the EQ5D-3L index.
Conclusion: Our results provide evidence for a possible correlation of allergies (e.g. against insect venom, food/food additives, and drugs) and/or urticaria with a reduced QoL and a higher depression rate. Patients particularly indicated restrictions for the dimensions, pain/discomfort as well as anxiety/depression. It might be beneficial to implement a standardized questionnaire as a regular screening method for evaluating the mental health status of patients with allergies and/or urticaria.
References
2. Uzzaman A, Cho SH. Chapter 28: Classification of hypersensitivity reactions. Allergy Asthma Proc. 2012;33(Suppl 1):96–99. 10.2500/aap.2012.33.3561
3. Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC. Immunologic principles of allergic disease. J Dtsch Dermatol Ges. 2007;5(11):1015–1028. 10.1111/j.1610-0387.2007.06538.x
4. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1(8009):466–469. 10.1016/S0140-6736(77)91953-5
5. Bloom B, Jones LI, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2012. Vital Healt stat 10. 2013 Dex;(258):1-81. Table 2.
6. Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011;128(1):e9–e17. 10.1542/peds.2011-0204
7. Worm M, Jappe U, Kleine-Tebbe J, Schafer C, Reese I, Saloga J, et al. Food allergies resulting from immunological cross-reactivity with inhalant allergens: guidelines from the German Society for Allergology and Clinical Immunology (DGAKI), the German Dermatology Society (DDG), the Association of German Allergologists (AeDA) and the Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int. 2014;23(1):1–16. 10.1007/s40629-014-0004-6
8. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161(1):15–21. 10.1001/archinte.161.1.15
9. Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol. 2002;110(1):174–182. 10.1067/mai.2002.125827
10. Clark S, Long AA, Gaeta TJ, Camargo CA. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol. 2005;116(3):643–649. 10.1016/j.jaci.2005.06.026
11. Schafer T, Ring J. Epidemiology of urticaria. Monogr Allergy. 1993;31:49–60.
12. Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79(4):599–614. 10.1016/j.jaad.2018.01.020
13. Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: a sex-and age-adjusted population analysis. J Am Acad Dermatol. 2019;81(1):152–156. 10.1016/j.jaad.2019.02.064
14. Torres MJ, Blanca M, Fernandez J, Romano A, Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy. 2003;58(10):961–972. 10.1034/j.1398-9995.2003.00280.x
15. Quigley J, Sanders GM. Food allergy in patients seeking mental health care: what the practicing psychiatrist should know. Curr Psychiatry Rep. 2017;19(12):99. 10.1034/j.1398-9995.2003.00280.x
16. Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9:42. 10.1186/s13601-019-0278-3
17. Tat TS. Higher levels of depression and anxiety in patients with chronic urticaria. Med Sci Monit. 2019;25:115–120. 10.12659/MSM.912362
18. Szende A, Janssen B, Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. Dordrecht; 2014.
19. Finlay AY, Khan GK. Dermatology life quality index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. 10.1111/j.1365-2230.1994.tb01167.x
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. 10.1001/archpsyc.1961.01710120031004
21. Jacobi F, Hofler M, Strehle J, Mack S, Gerschler A, Scholl L, et al. [Erratum to: mental disorders in the general population. Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Nervenarzt. 2016;87(1):88–90. 10.1007/s00115-015-4458-7
22. Jacobi F, Hofler M, Strehle J, Mack S, Gerschler A, Scholl L, et al. [Mental disorders in the general population: study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Nervenarzt. 2014;85(1):77–87. 10.1007/s00115-013-3961-y
23. Melrose S. Seasonal affective disorder: an overview of assessment and treatment approaches. Depress Res Treat. 2015;2015:178564. 10.1155/2015/178564
24. Savage J, Johns CB. Food allergy: epidemiology and natural history. Immunol Allergy Clin North Am. 2015;35(1):45–59. 10.1016/j.iac.2014.09.004
25. Kakli HA, Riley TD. Allergic rhinitis. Prim Care. 2016;43(3):465–475. 10.1016/j.pop.2016.04.009
26. Kelly C, Gangur V. Sex disparity in food allergy: evidence from the PubMed database. J Allergy (Cairo). 2009;2009:159845. 10.1155/2009/159845
27. Maurer M, Costa C, Gimenez Arnau A, Guillet G, Labrador-Horrillo M, Lapeere H, et al. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin Exp Allergy. 2020;50(10):1166–1175. 10.1111/cea.13716
28. Berufsunfähigkeit – Meistens gibt die Seele auf ÄrzteZeitung. 2017.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.